Background: The most frequent cause of maternal deaths in developing
countries is severe postpartum hemorrhage. We aimed to determine the risk factors
affecting blood and/or blood product transfusion in patients with postpartum
hemorrhage who were admitted to intensive care unit and to reveal clinical
outcomes. Methods: After local ethics committee approval, this
retrospective study included patients monitored due to postpartum hemorrhage in
the 2nd stage intensive care between 1 January 2019–1 January 2020. Patients were
divided into two groups as those requiring transfusion (n = 156) and those not
requiring transfusion (n = 162). Patients data such as age, blood group,
pregnancy week, gravida, parity, previous cesarean history, maternal comorbidity
were recorded. The form of delivery, trial of labor, cesarean type, indications,
anesthesia type, multiple pregnancy, placental anomalies and predelivery
hemoglobin were noteded. The amount of blood products used were identified.
Results: High parity (P = 0.002), normal vaginal delivery rate
(P
Announcements
Open Access
Original Research
Can requirement for blood transfusion be predicted before delivery? Analysis of risk factors for blood transfusion in patients with postpartum hemorrhage
Show Less
1
Gazi Yaşargil Training and Research Hospital, Anesthesiology and Reanimation Clinic, 21010 Diyarbakır, Turkey
*Correspondence: fikretsalik@gmail.com (Fikret Salık)
Clin. Exp. Obstet. Gynecol. 2021, 48(3), 572–577;
https://doi.org/10.31083/j.ceog.2021.03.2401
Submitted: 6 December 2020 | Revised: 12 January 2021 | Accepted: 8 February 2021 | Published: 15 June 2021
(This article belongs to the Special Issue CoVID-19 in OB/GYN)
Copyright: © 2021 The Author(s). Published by IMR Press.
This is an open access article under the CC BY 4.0 license (https://creativecommons.org/licenses/by/4.0/).
Abstract
Keywords
Postpartum hemorrhage
Blood transfusion
Intensive care unit